A novel VIMatype metalloabetaalactamase (VIMa14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit

A novel VIMatype metalloabetaalactamase (VIMa14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit

A Pseudomonas aeruginosa highly resistant to carbapenems was isolated in a neonatal intensive care unit in Palermo, Italy. The strain was found to carry a novel VIM-type enzyme, classified as VIM-14. The novel enzyme differs from VIM-4 in a G31S mutation. VIM-14 was harboured in a class 1 integron w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical microbiology and infection 2011-05, Vol.17 (5), p.722-724
Hauptverfasser: Mazzariol, A, Mammina, C, Koncan, R, Di Gaetano, V, Di Carlo, P, Cipolla, D, Corsello, G, Cornaglia, G
Format: Artikel
Sprache:eng
Schlagworte:
Carbapenems
Clinical isolates
Enzymes
Intensive care units
Mutation
Neonates
Pseudomonas aeruginosa
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A Pseudomonas aeruginosa highly resistant to carbapenems was isolated in a neonatal intensive care unit in Palermo, Italy. The strain was found to carry a novel VIM-type enzyme, classified as VIM-14. The novel enzyme differs from VIM-4 in a G31S mutation. VIM-14 was harboured in a class 1 integron with a new organization. The integron carried the genes aac7, blaVIM-14, blaOXA-20 and aac4 in that order.Original Abstract: Clin Microbiol Infect 2011; 17: 722-724
ISSN:1198-743X
1469-0691
DOI:10.1111/j.1469-0691.2010.03424.x